Arcadia Biosciences Inc
General ticker "RKDA" information:
- Sector: Consumer Staples
- Industry: Food Products
- Capitalization: $6.4M
Arcadia Biosciences Inc follows the US Stock Market performance with the rate: 33.7%.
Estimated limits based on current volatility of 4.3%: low 5.75$, high 6.27$
Factors to consider:
- US accounted for 88.8% of revenue in the fiscal year ended 2022-12-31
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [5.90$, 19.94$]
- 2023-12-31 to 2024-12-30 estimated range: [3.55$, 11.11$]
Financial Metrics affecting the RKDA estimates:
- Negative: Non-GAAP EPS, $ of -26.31 <= 0.10
- Negative: Operating profit margin, % of -66.09 <= 1.03
- Negative: Operating cash flow per share per price, % of -64.55 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -1.24 <= 3.85
- Negative: negative Net income
- Negative: Industry inventory ratio change (median), % of 1.41 > 0.49
- Negative: Industry earnings per price (median), % of 0 <= 1.31
- Negative: 0.14 < Interest expense per share, $ of 0.48
Short-term RKDA quotes
Long-term RKDA plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $8.03MM | $6.78MM | $9.96MM |
| Operating Expenses | $29.63MM | $42.31MM | $29.36MM |
| Operating Income | $-21.59MM | $-35.53MM | $-19.40MM |
| Non-Operating Income | $15.44MM | $19.39MM | $3.81MM |
| Interest Expense | $0.05MM | $0.02MM | $0.29MM |
| R&D Expense | $7.96MM | $3.89MM | $1.51MM |
| Income(Loss) | $-6.15MM | $-16.13MM | $-15.60MM |
| Taxes | $-0.12MM | $0.00MM | $0.01MM |
| Profit(Loss) | $-6.03MM | $-16.13MM | $-15.61MM |
| Stockholders Equity | $27.73MM | $31.09MM | $21.03MM |
| Inventory | $3.81MM | $4.43MM | $2.57MM |
| Assets | $47.35MM | $43.92MM | $28.92MM |
| Operating Cash Flow | $-30.22MM | $-25.87MM | $-13.98MM |
| Capital expenditure | $2.33MM | $1.01MM | $0.07MM |
| Investing Cash Flow | $17.28MM | $16.61MM | $1.42MM |
| Financing Cash Flow | $20.56MM | $21.90MM | $4.52MM |
| Earnings Per Share* | $-24.20 | $-30.33 | $-26.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.